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approximately 10%. The rates of SSI varied depending on the surveillance period, 
data collection method, and surgical procedure. The incidence of SSI was high for 
cardiovascular (5–18%) and gastrointestinal (6–16%) surgery. The rates of SSI 
appeared lower for neurosurgery (0.8–2.5%), although those studies only considered 
SSI cases before discharge from hospital. Diabetes and obesity were found to increase 
the risk of SSI by over 70%. Other signiﬁ cant risk factors identiﬁ ed include surgery 
duration and wound classiﬁ cation. The most common pathogens in SSIs were Staphy-
lococcus aureus, Pseudomonas aeruginosa and Escherichia coli. SSIs were found to 
extend hospital stay by 5–18 days and increase treatment cost by 4–30%. The esti-
mated cost of hospitalization was signiﬁ cantly higher in patients with SSI compared 
to patients without SSI (29,000 vs. 16,000 rupees, P < 0.001). CONCLUSIONS: In 
India, where an estimated 72% of health-care expense is out-of-pocket, the additional 
cost associated with SSI (treatment, loss of ability to work) represents a signiﬁ cant 
burden to patients and their families. The increase in hospital stay also lays additional 
burden to an already resource-constrained health-care system. Interventions aimed at 
reducing SSI would provide cost-savings and improve the efﬁ ciency of the health-care 
system. 
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OBJECTIVES: To conduct a systematic review of literature on the epidemiological 
and economic burden of surgical site infection (SSI) in Australia. METHODS: A lit-
erature search of the EMBASE and Medline databases was conducted. The search was 
limited to 1995–2010 to ensure the pertinence of the data. Searches to identify epide-
miological and economic studies were conducted separately. Relevant studies were 
identiﬁ ed using pre-deﬁ ned criteria (i.e., reports the rate, risk factors, cost of SSI; 
conducted in a hospital setting; not an intervention study). RESULTS: Thirty-ﬁ ve 
studies were included in this review. Differences in study design (surveillance period, 
data collection method, surgical procedure) made it difﬁ cult to synthesise data to 
derive a single estimate of SSI in Australia. The overall incidence of SSI in Australia 
is approximately 5–10%. However, the rate of SSI varied across different procedures: 
higher rates were seen following gastrointestinal (~11%) and cardiovascular (6–13%) 
surgery, while the rates for orthopedic (4.7–8%) and gynecological surgery (2.3–10%) 
appeared lower. Risk factors identiﬁ ed include diabetes and obesity, which increased 
the risk of SSI by 60–180%. The National Nosocomial Infections Surveillance (NNIS) 
risk index was positively correlated with the risk of developing an SSI. The most 
common organisms identiﬁ ed in SSIs were Staphylococcus aureus and Pseudomonas 
aeruginosa. The hospitalization cost attributable to SSI is estimated at approximately 
AUD$54 million annually. With a large proportion of SSIs occurring after discharge 
from hospital, the incidence of SSI is likely underestimated. Post-discharge SSI, in turn, 
increases the burden to community health services. Indirect costs, such as loss of 
productivity, further add to the economic burden of SSI. CONCLUSIONS: The 
incidence and cost estimates demonstrate that SSI represents a signiﬁ cant burden to 
the Australian health-care system. Interventions aimed at reducing SSI would provide 
cost-savings and improve the efﬁ ciency of the health-care system. 
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OBJECTIVES: To conduct a systematic review of literature on the epidemiological 
and economic burden of surgical site infection (SSI) in Japan. METHODS: A literature 
search of the EMBASE and Medline databases was conducted. The search was limited 
to 1995–2010 to ensure the pertinence of the data. Searches to identify epidemiological 
and economic studies were conducted separately. Relevant studies were identiﬁ ed 
using pre-deﬁ ned criteria (i.e., reports the rate, risk factors, cost of SSI; conducted in 
a hospital setting; not an intervention study). RESULTS: Thirty-ﬁ ve studies (22 ret-
rospective, 12 prospective and one case-control study) were included. Differences in 
study design, surgical procedure and surveillance period made it difﬁ cult to synthesise 
data to derive a single estimate of SSI in Japan. The overall incidence of SSI in Japan 
is approximately 5–10%. The rate of SSI was higher following gastrointestinal surgery 
(~20%), and lower for cardiovascular (<6.5%) and orthopedic (<1%) surgery. Super-
ﬁ cial SSI occurred most frequently accounting for 30–87% of all SSIs. The National 
Nosocomial Infections Surveillance (NNIS) risk index was positively correlated with 
the risk of developing an SSI. Procedure-associated risk factors (e.g., surgical tech-
nique, surgery duration) were also found to signiﬁ cantly increase the risk of SSI. The 
most common organisms identiﬁ ed in SSIs were Staphylococcus aureus and Pseudo-
monas aeruginosa. None of the studies identiﬁ ed in this review examined the economic 
burden of SSI in Japan. However, several studies showed that SSIs were associated 
with a signiﬁ cant increase in ICU and hospital stay (6–27 additional days). CONCLU-
SIONS: SSI represents a substantial burden on the health-care system and patients, 
mainly attributable to the extended length of stay in hospital and additional cost of 
treatment required. Consequently, strategies and interventions aimed at reducing the 
incidence of SSIs could provide cost-savings and improve the efﬁ ciency of the Japanese 
health-care system. 
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OBJECTIVES: The study aimed to assess the clinical and socio-demographic factors 
associated with pulmonary and extra pulmonary tuberculosis in Yemen. METHODS: 
A cross-sectional study was carried out among 160 Pulmonary Tuberculosis (PTB) 
and 160 Extra Pulmonary Tuberculosis (EPTB) patients diagnosed and treated in a 
TB center in Sana’a, the capital city of Yemen. Socio demographic, clinical and labora-
tory data and types of drug regimen used in treatment were collected from TB patients 
and medical records from the TB center. Risk factors for EPTB patients and PTB 
patients were identiﬁ ed through structured questionnaire by interviewing. RESULTS: 
The female to male ratio was 1.2 and 1.6 for PTB and EPTB, respectively. The median 
age for PTB patients was 28 and 30 for EPTB patients. It was also found that the TB 
patients with low educational level amounted 52% and 49% in PTB and EPTB 
respectively. This study illustrated that the majority of smokers were males 64% for 
PTB and 58% for EPTB, whose age ranging between 15–54 in both PTB and EPTB 
cases. This study found the extra pulmonary tuberculosis patients diagnosed in private 
hospital and clinics (41%) more than pulmonary tuberculosis patients (26%) There 
were signiﬁ cant differences in vaccination in case of employed patients of PTB than 
non employed patients and educated patients of PTB than non educated patients (P 
= 0.02 and P = 0.036) respectively. There was also signiﬁ cant difference in vaccination 
in case of employed patients of EPTB than nonemployed patients (P < 0.0001). 
CONCLUSIONS: In conclusion, female and younger ages were higher in both EPTB 
and PTB. The EPTB patients diagnosed in private hospital and clinics were more than 
PTB patients. The EPTB patients have less monthly income than pulmonary TB. Vac-
cination has strong correlation with education and employment in case of PTB and 
EPTB patients. 
PIN7
ANTIFUNGAL TREATMENT FOR INVASIVE CANDIDIASIS: SYSTEMATIC 
REVIEW AND META-ANALYSIS
Oh JJ1, Hwang JA2, Ko SK1
1Pﬁ zer Pharmaceuticals Korea Ltd, Seoul, South Korea; 2Korea Environment Health Institute, 
Seoul, South Korea
OBJECTIVES: This study aimed to compare the effects of different antifungal thera-
pies for invasive candidiasis. METHODS: Literature searches through MEDLINE, and 
the Cochrane Database were performed with the following search terms: names of 
speciﬁ c antifungal agents, candidiasis and candidemia, from inception to December 
2009. We included all randomized controlled trials (RCT), observational studies, 
cohort studies and review articles that compared different antifungal agents for the 
treatment of invasive candidiasis and other form of candidiasis. Then we performed 
a meta-analysis with extracted RCTs. The primary outcome was treatment success 
and the secondary outcome was all-cause mortality. Relative risks (RRs) with 95% 
conﬁ dence intervals (Cis) were pooled. RESULTS: Through systematic review (SR), a 
total number of nine RCTs, four SR and meta-analysis, one observational study were 
extracted. Meta-analysis included nine RCTs enrolling a total of 1527 patients. For 
primary analysis of treatment success, we pooled 5 trials comparing ﬂ uconazole to 
amphotericin B, Relative Risk (RR) 0.92 (95% CI, 0.81–1.03). We also pooled two 
trials of amphotericin B versus echinocandins and yielded a RR of 1.00 (95% CI, 
0.90–1.10). One study compared anidulafungin to ﬂ uconazole resulting in a RR of 
1.26 (95% CI, 1.06–1.51) in favor of anidulafungin. For all-cause mortality analysis, 
ﬁ ve trials assessing ﬂ uconazole to amphotericin B were pooled and yielded a RR of 
0.84 (95% CI, 0.64–1.12). The pooled RR of two trials comparing amphotericin B 
to echinocandins was 0.95 (95% CI, 0.73–1.23). Anidulafungin versus ﬂ uconazole 
resulted in a RR of 0.73 (95% CI, 0.48–1.10). CONCLUSIONS: All assessed anti-
fungal agents showed similar efﬁ cacy on treatment success and all-cause mortality, 
but anidulafungin revealed the signiﬁ cant high rate of treatment success compared to 
ﬂ uconazole. 
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OBJECTIVES: To evaluate the clinical effectiveness of the 2009–2010 seasonal inﬂ u-
enza vaccine in preventing Inﬂ uenza-like illness (ILI) in healthy Indian children of age 
6 months to 18 years. METHODS: A prospective observational cohort study was 
carried out from September, 2009 to February, 2010, at a private outpatient pediatric 
setting in Northern India. All the enrolled children were followed monthly through 
telephonic interview of their parents for development of ILI. The visits to physician 
for any acute respiratory tract infection (ARI) were also recorded. ILI was deﬁ ned as 
per ICD-10. Children having one shot and two shots of inﬂ uenza vaccine were deﬁ ned 
as partially vaccinated and fully vaccinated, respectively. Multiple logistic regression 
was used to calculate the association between vaccination status and ILI. RESULTS: 
A total of 294 children, vaccinated cohort (N = 153) and unvaccinated cohort (N = 
141) were enrolled in the study. There was a statistically signiﬁ cant reduction in ILI 
(OR 0.57 [0.33–0.99], P < 0.05) and visits to physician for ARI (OR 0.42 [0.22–0.79], 
